Previously treated cases tested for RR-/MDR-TB in Singapore
Singapore: Previously treated cases tested for RR-/MDR-TB was 49.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Singapore, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Singapore stood at 49.0%. That is the lowest value across all 20 years on record.
That represents a change of down 21.0% on the previous year and down 19.7% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Singapore peaked at 100.0% in 2020 and was at its lowest, 49.0%, in 2024.
That places Singapore 151st out of 180 countries with data for 2024, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Singapore, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 69.0% | — |
| 2006 | 62.0% | -10.1% |
| 2007 | 70.0% | +12.9% |
| 2008 | 68.0% | -2.9% |
| 2009 | 64.0% | -5.9% |
| 2010 | 61.0% | -4.7% |
| 2011 | 64.0% | +4.9% |
| 2012 | 58.0% | -9.4% |
| 2013 | 65.0% | +12.1% |
| 2014 | 61.0% | -6.2% |
| 2015 | 64.0% | +4.9% |
| 2016 | 65.0% | +1.6% |
| 2017 | 66.0% | +1.5% |
| 2018 | 98.0% | +48.5% |
| 2019 | 83.0% | -15.3% |
| 2020 | 100.0% | +20.5% |
| 2021 | 92.0% | -8.0% |
| 2022 | 58.0% | -37.0% |
| 2023 | 62.0% | +6.9% |
| 2024 | 49.0% | -21.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 66.6% | 62.0% | 70.0% | 5 |
| 2010s | 68.5% | 58.0% | 98.0% | 10 |
| 2020s | 72.2% | 49.0% | 100.0% | 5 |
Countries ranked near Singapore
More health data for Singapore
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5225 % change on previous year (2090)
- Heat deaths vs projected death rates 1,924 (2090)
- Un projection of annual infant deaths 13 (2100)
- Population ages 0-14, female, annual growth rate 1.32 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0571 units per person (2025)
- Population ages 0-14, male, annual growth rate 1.19 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0598 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Singapore?
- Previously treated cases tested for rr-/mdr-tb in Singapore was 49.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Singapore?
- The highest recorded value was 100.0% in 2020.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Singapore?
- The lowest recorded value was 49.0% in 2024.
- How does Singapore rank for previously treated cases tested for rr-/mdr-tb?
- Singapore ranks 151st out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Singapore?
- Over the last ten years it is down 19.7%. The long-run trend across the full record is rising.
- Where does this Singapore data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).